RecruitingNCT05097820
Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants
Sponsor
University Hospital, Ghent
Enrollment
100 participants
Start Date
Feb 5, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
To analyze the short and long term postoperative clinical outcome and patient satisfaction of silicone gel-filled testicular implants.
Eligibility
Min Age: 0 YearsMax Age: 110 Years
Plain Language Summary
Simplified for easier understanding
This study is following people who receive a silicone gel testicular implant (called a SEBBIN implant) after losing one or both testicles — for example after cancer treatment, injury, or a birth defect — to track the long-term safety and outcomes of the device.
**You may be eligible if...**
- You are an adult or child who needs (or recently received) a testicular implant
- You are receiving a unilateral or bilateral (one or both sides) testicular implant
- You have been informed about the study and signed the consent form
- If you are French, you are affiliated with the French Social Security system
**You may NOT be eligible if...**
- You already have silicone implants elsewhere (other than a penile prosthesis)
- You have a connective tissue disease such as lupus, scleroderma, Sjogren syndrome, or rheumatoid arthritis
- You have inflammatory joint disease, fibromyalgia, or chronic fatigue syndrome
- You have any condition that significantly impairs wound healing
- A custom-designed (non-standard) implant is required for your surgery
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPlacement of testicular prosthesis
The surgical implantation of one or two testicular prostheses on request of the patient
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05097820
Related Trials
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
NCT0651561314 locations
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
NCT074075821 location
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
NCT071471661 location
DESTINY-PANTUMOUR04
NCT0712400017 locations
Brain Health in Transgender Adults
NCT076247471 location